Developing treatments to help people affected by radiation exposure
Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes
This study is working on new treatments to help people who might be harmed by radiation exposure, especially in emergencies, and it's being done by a team of experts from different universities to find the best ways to keep everyone safe and healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10861014 on NIH RePORTER |
What this research studies
The INTERACT Consortium focuses on creating safe and effective medical treatments to address the immediate and long-term health effects of radiation exposure. This research involves a collaborative effort among experts from multiple universities to identify new therapeutic targets and advance promising treatments through rigorous testing and development. Patients may benefit from innovative therapies designed to mitigate the harmful effects of radiation in the event of a nuclear or radiological emergency. The research employs a multidisciplinary approach, utilizing various animal models to ensure comprehensive evaluation of potential countermeasures.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who may be at risk of radiation exposure due to public health emergencies.
Not a fit: Patients who are not adults or those who are not at risk of radiation exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide critical medical treatments that protect and restore health for individuals exposed to harmful radiation.
How similar studies have performed: Previous research has shown promise in developing medical countermeasures for radiation exposure, but this consortium aims to advance these efforts further with a novel, collaborative approach.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Carrier, France — University of Maryland Baltimore
- Study coordinator: Carrier, France
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.